First-line tailored treatment of Helicobacter pylori in a country with increasing resistance rates

被引:0
|
作者
Brennan, D. E. [1 ]
Hussey, M. [1 ]
Tighe, D. [1 ]
O'Morain, C. [1 ]
Smith, S. [1 ]
McNamara, D. [1 ]
机构
[1] Trinity Coll Dublin, Dublin, Ireland
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
W3.4
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Tailored therapy based on clarithromycin resistance is effective for the first-line therapy of Helicobacter pylori
    Moon, S.
    Kang, H.
    Lim, C.
    Oh, J.
    [J]. HELICOBACTER, 2020, 25 : 29 - 29
  • [2] Levofloxacin in first-line treatment of Helicobacter pylori infection
    Rispo, A.
    Di Girolamo, E.
    Cozzolino, A.
    Bozzi, R.
    Morante, A.
    Pasquale, L.
    [J]. HELICOBACTER, 2007, 12 (04) : 364 - 365
  • [3] Noninvasive molecular analysis of Helicobacter pylori : Is it time for tailored first-line therapy?
    Enzo Ierardi
    Floriana Giorgio
    Andrea Iannone
    Giuseppe Losurdo
    Mariabeatrice Principi
    Michele Barone
    Antonio Pisani
    Alfredo Di Leo
    [J]. World Journal of Gastroenterology, 2017, (14) : 2453 - 2458
  • [4] Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
    Ierardi, Enzo
    Giorgio, Floriana
    Iannone, Andrea
    Losurdo, Giuseppe
    Principi, Mariabeatrice
    Barone, Michele
    Pisani, Antonio
    Di Leo, Alfredo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (14) : 2453 - 2458
  • [5] Different treatment choice for first-line treatment of Helicobacter pylori in an area with a high antibiotic resistance
    Basyigit, Sebahat
    Kefeli, Ayse
    Yeniova, Abdullah Ozgur
    Uzman, Metin
    Nazligul, Yasar
    Aktas, Bora
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 : 293 - 294
  • [6] Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment
    Cisaro, F.
    Astegiano, M.
    De Angelis, C.
    Saracco, G.
    Rizzetto, M.
    Pellicano, R.
    [J]. PANMINERVA MEDICA, 2011, 53 (02) : 138 - 138
  • [7] Amoxycillin plus tetracycline as first-line Helicobacter pylori treatment
    Pellicano, R.
    Fagoonee, S.
    Astegiano, M.
    Morgando, A.
    Cisaro, F.
    Rizzetto, M.
    [J]. MINERVA MEDICA, 2011, 102 (02) : 169 - 170
  • [8] Tailored therapy guided by genotypic resistance of clarithromycin and levofloxacin detected by polymerase chain reaction in the first-line treatment of Helicobacter pylori infection
    Li, Cai Ling
    Zhou, Kai
    Zhang, Yue Xi
    Suo, Bao Jun
    Tian, Xue Li
    Zhang, Yu Xin
    Ren, Xin Lu
    Shi, Yan Yan
    Zhou, Li Ya
    Song, Zhi Qiang
    [J]. JOURNAL OF DIGESTIVE DISEASES, 2024, 25 (01) : 36 - 43
  • [9] Hybrid Therapy as First-Line Regimen for Helicobacter pylori Eradication in Populations with High Antibiotic Resistance Rates
    Song, Zhiqiang
    Zhou, Liya
    Zhang, Jianzhong
    He, Lihua
    Bai, Peng
    Xue, Yan
    [J]. HELICOBACTER, 2016, 21 (05) : 382 - 388
  • [10] Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
    Diogo Branquinho
    Nuno Almeida
    Carlos Gregório
    José Eduardo Pina Cabral
    Adriano Casela
    Maria Manuel Donato
    Luís Tomé
    [J]. BMC Gastroenterology, 17